Zobrazeno 1 - 10
of 10 483
pro vyhledávání: '"CDK"'
Publikováno v:
CDK Global, Inc. MarketLine Company Profile. 10/14/2021, p1-22. 22p.
Publikováno v:
CDK Global, Inc. MarketLine Company Profile. 9/30/2020, p1-21. 21p.
Publikováno v:
CDK Global, Inc. MarketLine Company Profile. 10/31/2019, p1-20. 20p.
Autor:
Kapko, Matt
Publikováno v:
Cybersecurity Dive. 7/1/2024, pN.PAG-N.PAG. 1p.
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-20 (2024)
Abstract In cells, signal transduction heavily relies on the intricate regulation of protein kinases, which provide the fundamental framework for modulating most signaling pathways. Dysregulation of kinase activity has been implicated in numerous pat
Externí odkaz:
https://doaj.org/article/e575bb36a35e48b981305c837596e13a
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Super enhancers (SEs) consist of clusters of enhancers, harboring an unusually high density of transcription factors, mediator coactivators and epigenetic modifications. SEs play a crucial role in the maintenance of cancer cell identity and
Externí odkaz:
https://doaj.org/article/ffc544723bc145c0b582e5e65ce63fa7
Autor:
Kapko, Matt
Publikováno v:
Cybersecurity Dive. 6/27/2024, pN.PAG-N.PAG. 1p.
Autor:
Kapko, Matt
Publikováno v:
Cybersecurity Dive. 6/24/2024, pN.PAG-N.PAG. 1p.
Autor:
Zhixuan Xiong, Jingjing Cao, Ke Wang, Yuling Yang, Ying Hu, Jiangjiang Nie, Qinghua Zeng, Yu Hu, Lina Zhu, Xiangzhi Li, Huansheng Wu
Publikováno v:
Poultry Science, Vol 103, Iss 7, Pp 103833- (2024)
ABSTRACT: The family of cell cycle-dependent kinases (CDKs) serves as catalytic subunits within protein kinase complexes, playing a crucial role in cell cycle progression. While the function of CDK proteins in regulating mammalian innate immune respo
Externí odkaz:
https://doaj.org/article/480ec54618624104a336b24ef74c425f
Autor:
Diana Malarikova, Radek Jorda, Kristyna Kupcova, Jana Senavova, Alexandra Dolnikova, Eva Pokorna, Dmitry Kazantsev, Kristina Nozickova, Dana Sovilj, Celine Bellanger, David Chiron, Ladislav Andera, Vladimir Krystof, Miroslav Strnad, Karel Helman, Magdalena Klanova, Marek Trneny, Ondrej Havranek, Pavel Klener
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-4 (2024)
Abstract Background Mantle cell lymphoma (MCL) is a chronically relapsing malignancy with deregulated cell cycle progression. We analyzed efficacy, mode of action, and predictive markers of susceptibility to palbociclib, an approved CDK 4/6 inhibitor
Externí odkaz:
https://doaj.org/article/66f0f83138da43c8bb386bfcf004df4c